Refine by
Tissue Engineered Articles & Analysis
72 news found
The HZ-PEG-HZ (1K) product is critical for applications including: l Controlled Drug Delivery Systems: Leveraging its pH-sensitive hydrazone bonds for targeted and controlled release of active pharmaceutical ingredients in specific physiological environments (e.g., tumor microenvironments, endosomes, lysosomes). l Bioconjugation and Crosslinking: Facilitating the creation of stable linkages in ...
These highly purified nanoparticles offer exceptional performance and reliability in various research and commercial applications, such as drug delivery, nanosensors, photothermal therapy, antimicrobial agents, biomedical imaging, catalysis, and tissue engineering. Silver nanoparticles (AgNPs) are increasingly being used in various fields due to their unique ...
Key Applications in Medicine: Multi-arm PEG linkers from Biopharma PEG are vital in several advanced medical applications: l Controlled Drug Release: The cross-linked hydrogels formed by multi-arm PEGs provide a stable matrix for the sustained and controlled release of drugs, ensuring targeted delivery and enhanced therapeutic efficacy. l 3D Cell Culture: Multi-arm PEG hydrogels create a ...
In the field of regenerative medicine and tissue engineering, the demand for collagen-based biomaterials is rapidly increasing. ...
CELLINK, a global leader in bioprinting technologies, is proud to announce a pioneering innovation in the field of regenerative medicine and tissue engineering with the launch of CELLINK Vivoink, the first-ever medical-grade bioink specially designed to support researchers on their clinical translational journey. CELLINK Vivoink is optimized for superior ...
ByCELLINK
This partnership aims to facilitate the utilization of advanced bioprinting technologies and promote cutting-edge research in the fields of drug discovery, cancer research, and tissue engineering. The Centre of Excellence will house state-of-the-art CELLINK bioprinters, including the flagship BIO X6 and BIONOVA X bioprinters, a range of bioinks and the leading ...
ByCELLINK
With a comprehensive portfolio of world-class 3D bioprinters and bioinks CELLINK’s technology enables the printing of human tissues and organs, which enable faster and more accurate models for drug development, while replacing animal experiments and paving the way to save lives by reducing organ rejection and potentially solve the problem with lack of donors. 2022 ...
ByCELLINK
Our lead product is 3D cardiac engineered heart tissues (EHTs) fabricated from human induced pluripotent stem cell (iPSC) derived cardiomyocytes. ...
The Microplate Reader Company – and InvivoSciences, Inc. – a leader in stem cell tissue engineering providing a novel solution in first-in-class drug discovery – announced today a strategic collaboration to market the time-dependent fluorescent assessment of engineered 3D heart tissues using advanced ...
Our unique combination of tissue engineering technology with assay automation and sample miniaturization offers a rapid and cost effective platform for unprecedented therapeutic discovery. ...
BOC Sciences declares that some of its peptide products have been proven applicable for osteoporosis treatment, which is a significant contribution to the therapeutic areas. Bone tissue engineering and the research surrounding peptides have expanded significantly over the last few decades. ...
After the entry into clinical phase announced in early July 2022, LATTICE MEDICAL, announces the success of the first breast reconstruction operation with the MATTISSE implant. The operation took place on July 12 at the Institute of Clinical Oncology, Tbilisi, Georgia. It was conducted by Pr Gia Nemsdaze and his team, and in the presence of the co-founders of Lattice Medical, Pr. Pierre ...
Polyethylene GlycolAlfa Chemistry provides a diverse spectrum of well-defined PEG products, including Dendrimer PEG, Multi-Arm PEG, Heterobifunctional Linear PEGs, Homobifunctional Linear PEGs, Monofunctional PEG, PEG Block Copolymer, Polyethylene Glycol Raw Material, and Y-Shaped PEG Derivatives for biomedical research including but not limited to drug administration, tissue ...
3DBio Therapeutics (3DBio), a clinical-stage regenerative medicine company, and the Microtia-Congenital Ear Deformity Institute announced they have conducted a human ear reconstruction using the AuriNovo™ implant, an investigational, patient-matched, 3D-bioprinted living tissue ear implant. The groundbreaking reconstructive procedure in the first-in-human Phase 1/2a ...
MatTek Life Sciences, a Boston-area tissue engineering company and a member of the BICO Group, announced today it has entered into a distribution agreement and strategic partnership with Cell4Pharma, a Netherlands-based company specializing in commercially available human renal cells, to distribute its products in the US as well as develop a new in vitro kidney ...
Senti Bio is developing next-generation cell and gene therapies engineered with gene circuits, which are designed to reprogram cells with biological logic to sense inputs, compute decisions and respond to their respective cellular environments. Senti Bio's oncology pipeline uses healthy adult donor-derived, natural killer (NK) cells engineered with chimeric ...
SILKBridge® is an absorbable medical device made of Bombyx mori silk fibroin and is intended for the surgical repair of peripheral nerve discontinuities to support regeneration across the defect. The tissue engineered technology at the core of SILKBridge® merges a deep-rooted cultural tradition and know-how with the most advanced technologies creating a ...
ByKLISBio
The Allegro 3D portfolio enables high precision and high speed bioprinting that is tailored for multi-well printing, providing life science companies the features needed for developing tissue constructs for regenerative medicine and drug testing workflows. ...
The company has a focus on developing technologies that will advance Health 4.0 Next Generation Core Industry Ecosystems that enable tissue engineering, diagnostics, multiomics, and cell line development. BICO’s technologies enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human ...
MatTek Life Sciences will produce and distribute EpiOral from its production facility in Slovakia, continuing the BICO groups’ focus on providing on-demand tissues to the European market. MatTek Life Sciences, a Boston-area tissue engineering company and a part of the BICO Group, announced today its European facility in Bratislava, ...